Rare diseases
Investigational molecules
Locations
Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
PolandStudy on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus
PolandStudy on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis
PolandStudy Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
PolandStudy Comparing MK-7684A with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
PolandLong-term Safety Study of Mavacamten for Adults with Hypertrophic Cardiomyopathy from Previous Trials
PolandStudy of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer
PolandStudy on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists
PolandStudy on the Effectiveness and Safety of Apalutamide and GnRH Agonist in Patients with High-Risk Prostate Cancer Undergoing Radiation Therapy
PolandStudy of Pembrolizumab and Lenvatinib for Patients with Advanced or Recurrent Endometrial Cancer
PolandStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
